The battle between weight-loss drugs continues. While studies show semaglutide (sold under the brand names Ozempic and Wegovy ...

Sometimes, it makes sense to skip insurance and instead take advantage of a health savings account or flexible savings ...

Of the total ER visits, nearly 70% involved GI issues, 15% of which led to hospitalization, according to a new study.

A new study analyzed how often people develop severe side effects after taking semaglutide — known by brand names Ozempic and ...

Researchers say semaglutide, the medication in Ozempic and Wegovy, may help reverse MASH, a progressive liver condition ...

A late-stage clinical study showed that this weight loss drug helped 2 out of 3 people with the life-threatening liver ...

Novo Nordisk's collaboration with telehealth providers offers semaglutide at $499/month, enhancing access for self-paying ...

Semaglutide, a drug commonly taken for weight loss, showed marked benefits for most patients in a trial for metabolic ...

Veru Inc. (NASDAQ: VERU), a late clinical stage biopharmaceutical company focused on developing innovative medicines for the ...

Novo Nordisk and a popular virtual health company are making Wegovy more accessible to millions of more Americans.

The drugmaker is racing to capture more patients now that many compounding pharmacies are restricted from making Wegovy ...

Lastly, if you’re on or about to get on one of the new weight loss drugs, walk the walk and be patient. It took you quite a ...